Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Colorectal Carcinoma
Interventions
DRUG

AMT2003

Trial Locations (1)

79111

Clinic SanaFontis, Freiburg im Breisgau

Sponsors
All Listed Sponsors
lead

Auron Healthcare GmbH

INDUSTRY

NCT00405561 - Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003 | Biotech Hunter | Biotech Hunter